KRAS and cancer: Nonetheless, with a better understanding of the KRAS protein structure and dynamics observed in the last 10 years, some light appears at the end of the tunnel for treating KRAS-mutated cancers, since some compounds targeting specific KRAS mutant forms have been developed and enrolled in clinical trials [18,19,23].